These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The characteristics of calculus formation in the kidneys of patients in families predisposed to urolithiasis]. Aleksandrov VP; Tiktinskiĭ OL; Novikov IF; Mikhaĭlichenko VV; Gnoian VP Urol Nefrol (Mosk); 1993; (4):16-9. PubMed ID: 8310557 [TBL] [Abstract][Full Text] [Related]
6. [Genetic and biochemical features of the monogenic hereditary urolithiasis]. Mikhaylenko DS; Prosyannikov MY; Baranova A; Nemtsova MV Biomed Khim; 2018 Aug; 64(4):315-325. PubMed ID: 30135278 [TBL] [Abstract][Full Text] [Related]
7. Genetic Risk Factors for Idiopathic Urolithiasis: A Systematic Review of the Literature and Causal Network Analysis. Taguchi K; Yasui T; Milliner DS; Hoppe B; Chi T Eur Urol Focus; 2017 Feb; 3(1):72-81. PubMed ID: 28720371 [TBL] [Abstract][Full Text] [Related]
8. The elementome of calcium-based urinary stones and its role in urolithiasis. Ramaswamy K; Killilea DW; Kapahi P; Kahn AJ; Chi T; Stoller ML Nat Rev Urol; 2015 Oct; 12(10):543-57. PubMed ID: 26334088 [TBL] [Abstract][Full Text] [Related]
9. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis]. Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687 [TBL] [Abstract][Full Text] [Related]
10. Do stones still kill? An analysis of death from stone disease 1999-2013 in England and Wales. Kum F; Mahmalji W; Hale J; Thomas K; Bultitude M; Glass J BJU Int; 2016 Jul; 118(1):140-4. PubMed ID: 26765522 [TBL] [Abstract][Full Text] [Related]
11. The mechanistic insight of polyphenols in calcium oxalate urolithiasis mitigation. Ahmed S; Hasan MM; Khan H; Mahmood ZA; Patel S Biomed Pharmacother; 2018 Oct; 106():1292-1299. PubMed ID: 30119199 [TBL] [Abstract][Full Text] [Related]
12. Urinary tract infection's etiopathogenic role in nephrolithiasis formation. Bauza JL; Pieras EC; Grases F; Tubau V; Guimerà J; Sabaté XA; Pizà P Med Hypotheses; 2018 Sep; 118():34-35. PubMed ID: 30037611 [TBL] [Abstract][Full Text] [Related]
13. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones. Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576 [TBL] [Abstract][Full Text] [Related]
14. [Urinary citrate excretion in children with calcium urolithiasis]. Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511 [TBL] [Abstract][Full Text] [Related]
15. [Methanaphylaxis of urolithiasis. Part 1. Factors for increasing incidence of urolithiasis. Current theories of renal stone formation]. Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG Urologiia; 2018 Oct; (4):161-169. PubMed ID: 30761808 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of urolithiasis in Crohn's disease. Ishii G; Nakajima K; Tanaka N; Hara H; Kato M; Ishii N Int J Urol; 2009 May; 16(5):477-80. PubMed ID: 19341366 [TBL] [Abstract][Full Text] [Related]
18. Some aspects of the management of bilateral calculus disease of the kidney. FLOCKS RH Calif Med; 1950 Jan; 72(1):7-13, illust. PubMed ID: 15408493 [TBL] [Abstract][Full Text] [Related]
19. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present]. Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782 [TBL] [Abstract][Full Text] [Related]
20. Metabolic assessment of recurrent and first renal calcium oxalate stone formers. Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]